_id
690db08eccc777a4e85d0b8e
Ticker
AREVF
Name
AREV NanoTec Brands Inc
Exchange
PINK
Address
18 - 91 Golden Drive, Coquitlam, BC, Canada, V3K 6R2
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.arevlifesciences.com
Description
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-TORE, a product based on organic plant nutrition for patients with overt clinical need for rational enhanced caloric intake and micronutrient supplementation. It also develops edible oils, moringa, hops, cannabis sativa, pharma, sea cucumber, ginseng, and functional fungi ingredients; and anti-virals and phytomedicinalization. In addition, the company flash-freezes active ingredients, oils, and oleoresins for use as ingredients in food, nutraceuticals, and other consumer products. The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. is based in Coquitlam, Canada.
Last Close
0.01
Volume
10000
Current Price
0.0005
Change
0
Last Updated
2026-01-20T15:37:45.315Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
15881
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-09-30
Revenue
0
Cost Of Revenue
13838
Gross Profit
-13838
Operating Expenses
27980
Operating Income
-11977
Interest Expense
945
Pretax Income
-28925
Net Income
-28925
Eps
-0.0009106690204378055
Dividends Per Share
-
Shares Outstanding
31762363
Income Tax Expense
53424
EBITDA
-14142
Operating Margin
-
Total Other Income Expense Net
-16948
Cash
1818
Short Term Investments
-
Receivables
55732
Inventories
0
Total Current Assets
68792
Property Plant Equipment
144502
Total Assets
213295
Payables
792069
Short Term Debt
145461
Long Term Debt
-
Total Liabilities
1376401
Equity
-1163106
Bs_currency_symbol
CAD
Depreciation
13838
Change In Working Capital
8558
Cash From Operations
-5584
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-5584
Cf_currency_symbol
CAD
PE
-
PB
-0.013654113640545229
ROE
2.4868756587963605
ROA
-13.56103049766755
FCF
-5584
Fcf Percent
-
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
1.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
1
Quarters > 0 > quarter
2023-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
13838
Quarters > 0 > income Statement > gross Profit
-13838
Quarters > 0 > income Statement > operating Expenses
27980
Quarters > 0 > income Statement > operating Income
-11977
Quarters > 0 > income Statement > interest Expense
945
Quarters > 0 > income Statement > pretax Income
-28925
Quarters > 0 > income Statement > net Income
-28925
Quarters > 0 > income Statement > eps
-0.0009106690204378055
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
31762363
Quarters > 0 > income Statement > income Tax Expense
53424
Quarters > 0 > income Statement > EBITDA
-14142
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-16948
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
1818
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
55732
Quarters > 0 > balance Sheet > inventories
0
Quarters > 0 > balance Sheet > total Current Assets
68792
Quarters > 0 > balance Sheet > property Plant Equipment
144502
Quarters > 0 > balance Sheet > total Assets
213295
Quarters > 0 > balance Sheet > payables
792069
Quarters > 0 > balance Sheet > short Term Debt
145461
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1376401
Quarters > 0 > balance Sheet > equity
-1163106
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-28925
Quarters > 0 > cash Flow > depreciation
13838
Quarters > 0 > cash Flow > change In Working Capital
8558
Quarters > 0 > cash Flow > cash From Operations
-5584
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-5584
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.0009106690204378055
Quarters > 0 > ratios > PB
-0.013654113640545229
Quarters > 0 > ratios > ROE
2.4868756587963605
Quarters > 0 > ratios > ROA
-13.56103049766755
Quarters > 0 > ratios > FCF
-5584
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2023-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
13838
Quarters > 1 > income Statement > gross Profit
-13838
Quarters > 1 > income Statement > operating Expenses
119534
Quarters > 1 > income Statement > operating Income
-119534
Quarters > 1 > income Statement > interest Expense
944
Quarters > 1 > income Statement > pretax Income
-120828
Quarters > 1 > income Statement > net Income
-120828
Quarters > 1 > income Statement > eps
-0.003804125026843878
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
31762363
Quarters > 1 > income Statement > income Tax Expense
944
Quarters > 1 > income Statement > EBITDA
-106046
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-5774
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
7402
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
54186
Quarters > 1 > balance Sheet > inventories
0
Quarters > 1 > balance Sheet > total Current Assets
73617
Quarters > 1 > balance Sheet > property Plant Equipment
158340
Quarters > 1 > balance Sheet > total Assets
231958
Quarters > 1 > balance Sheet > payables
772590
Quarters > 1 > balance Sheet > short Term Debt
145461
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1366141
Quarters > 1 > balance Sheet > equity
-1134183
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-120828
Quarters > 1 > cash Flow > depreciation
13838
Quarters > 1 > cash Flow > change In Working Capital
-9740
Quarters > 1 > cash Flow > cash From Operations
-115786
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
83905
Quarters > 1 > cash Flow > net Change In Cash
-31883
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.003804125026843878
Quarters > 1 > ratios > PB
-0.014002309592014693
Quarters > 1 > ratios > ROE
10.653307270519836
Quarters > 1 > ratios > ROA
-52.09046465308374
Quarters > 1 > ratios > FCF
-115786
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
32
Quarters > 2 > quarter
2023-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
13838
Quarters > 2 > income Statement > gross Profit
-13838
Quarters > 2 > income Statement > operating Expenses
166031
Quarters > 2 > income Statement > operating Income
-166031
Quarters > 2 > income Statement > interest Expense
939
Quarters > 2 > income Statement > pretax Income
-169370
Quarters > 2 > income Statement > net Income
-169370
Quarters > 2 > income Statement > eps
-0.005339977349314948
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
31717363
Quarters > 2 > income Statement > income Tax Expense
939
Quarters > 2 > income Statement > EBITDA
-154593
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-9909
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
39285
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
50770
Quarters > 2 > balance Sheet > inventories
0
Quarters > 2 > balance Sheet > total Current Assets
102872
Quarters > 2 > balance Sheet > property Plant Equipment
172178
Quarters > 2 > balance Sheet > total Assets
275051
Quarters > 2 > balance Sheet > payables
827703
Quarters > 2 > balance Sheet > short Term Debt
61556
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1288404
Quarters > 2 > balance Sheet > equity
-1013353
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-169370
Quarters > 2 > cash Flow > depreciation
13838
Quarters > 2 > cash Flow > change In Working Capital
52436
Quarters > 2 > cash Flow > cash From Operations
-24993
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
64222
Quarters > 2 > cash Flow > net Change In Cash
39191
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.005339977349314948
Quarters > 2 > ratios > PB
-0.015649710910215886
Quarters > 2 > ratios > ROE
16.713820356775972
Quarters > 2 > ratios > ROA
-61.577671050096164
Quarters > 2 > ratios > FCF
-24993
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
36
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
7209
Quarters > 3 > income Statement > cost Of Revenue
28827
Quarters > 3 > income Statement > gross Profit
-21618
Quarters > 3 > income Statement > operating Expenses
-95904
Quarters > 3 > income Statement > operating Income
103114
Quarters > 3 > income Statement > interest Expense
1156
Quarters > 3 > income Statement > pretax Income
79582
Quarters > 3 > income Statement > net Income
79582
Quarters > 3 > income Statement > eps
0.0025234196023300997
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
31537363
Quarters > 3 > income Statement > income Tax Expense
1157
Quarters > 3 > income Statement > EBITDA
109565
Quarters > 3 > income Statement > operating Margin
1430.3509502011375
Quarters > 3 > income Statement > total Other Income Expense Net
-23531
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
94
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
48767
Quarters > 3 > balance Sheet > inventories
0
Quarters > 3 > balance Sheet > total Current Assets
66612
Quarters > 3 > balance Sheet > property Plant Equipment
186016
Quarters > 3 > balance Sheet > total Assets
252629
Quarters > 3 > balance Sheet > payables
805483
Quarters > 3 > balance Sheet > short Term Debt
28834
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1205238
Quarters > 3 > balance Sheet > equity
-952609
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
79582
Quarters > 3 > cash Flow > depreciation
28826
Quarters > 3 > cash Flow > change In Working Capital
117775
Quarters > 3 > cash Flow > cash From Operations
-5524
Quarters > 3 > cash Flow > capital Expenditures
1477
Quarters > 3 > cash Flow > cash From Investing
-1477
Quarters > 3 > cash Flow > cash From Financing
-8074
Quarters > 3 > cash Flow > net Change In Cash
-15078
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
0.0025234196023300997
Quarters > 3 > ratios > PB
-0.016553151922772093
Quarters > 3 > ratios > ROE
-8.354109608454257
Quarters > 3 > ratios > ROA
31.501529911451183
Quarters > 3 > ratios > FCF
-7001
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.9711471771396865
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
49113
Annuals > 0 > income Statement > cost Of Revenue
19973
Annuals > 0 > income Statement > gross Profit
29140
Annuals > 0 > income Statement > operating Expenses
1292337
Annuals > 0 > income Statement > operating Income
-1388788
Annuals > 0 > income Statement > interest Expense
6089
Annuals > 0 > income Statement > pretax Income
-1444106
Annuals > 0 > income Statement > net Income
-1444106
Annuals > 0 > income Statement > eps
-0.04801702896690633
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
30074872
Annuals > 0 > income Statement > income Tax Expense
6089
Annuals > 0 > income Statement > EBITDA
-1310683
Annuals > 0 > income Statement > operating Margin
-2827.7401095432983
Annuals > 0 > income Statement > total Other Income Expense Net
-180909
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
94
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
48767
Annuals > 0 > balance Sheet > inventories
0
Annuals > 0 > balance Sheet > total Current Assets
66612
Annuals > 0 > balance Sheet > property Plant Equipment
186016
Annuals > 0 > balance Sheet > total Assets
252629
Annuals > 0 > balance Sheet > payables
805483
Annuals > 0 > balance Sheet > short Term Debt
28834
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1205238
Annuals > 0 > balance Sheet > equity
-952609
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-1444106
Annuals > 0 > cash Flow > depreciation
125591
Annuals > 0 > cash Flow > change In Working Capital
850354
Annuals > 0 > cash Flow > cash From Operations
-284386
Annuals > 0 > cash Flow > capital Expenditures
81811
Annuals > 0 > cash Flow > cash From Investing
-81811
Annuals > 0 > cash Flow > cash From Financing
207926
Annuals > 0 > cash Flow > net Change In Cash
-158219
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.04801702896690633
Annuals > 0 > ratios > PB
-0.015785527955331096
Annuals > 0 > ratios > ROE
151.59483061780855
Annuals > 0 > ratios > ROA
-571.6311270677555
Annuals > 0 > ratios > FCF
-366197
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-7.456213222568363
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
254996
Annuals > 1 > income Statement > cost Of Revenue
69879
Annuals > 1 > income Statement > gross Profit
185117
Annuals > 1 > income Statement > operating Expenses
1681949
Annuals > 1 > income Statement > operating Income
-1496832
Annuals > 1 > income Statement > interest Expense
46229
Annuals > 1 > income Statement > pretax Income
-990311
Annuals > 1 > income Statement > net Income
-990311
Annuals > 1 > income Statement > eps
-0.036051441555648836
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
27469387
Annuals > 1 > income Statement > income Tax Expense
46229
Annuals > 1 > income Statement > EBITDA
-797630
Annuals > 1 > income Statement > operating Margin
-587.0021490533185
Annuals > 1 > income Statement > total Other Income Expense Net
506521
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
158313
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
128982
Annuals > 1 > balance Sheet > inventories
19973
Annuals > 1 > balance Sheet > total Current Assets
338138
Annuals > 1 > balance Sheet > property Plant Equipment
284430
Annuals > 1 > balance Sheet > total Assets
622569
Annuals > 1 > balance Sheet > payables
475829
Annuals > 1 > balance Sheet > short Term Debt
75747
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
716077
Annuals > 1 > balance Sheet > equity
-93508
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-990311
Annuals > 1 > cash Flow > depreciation
146452
Annuals > 1 > cash Flow > change In Working Capital
-369965
Annuals > 1 > cash Flow > cash From Operations
-1469928
Annuals > 1 > cash Flow > capital Expenditures
12038
Annuals > 1 > cash Flow > cash From Investing
5419
Annuals > 1 > cash Flow > cash From Financing
1282406
Annuals > 1 > cash Flow > net Change In Cash
-139313
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.036051441555648836
Annuals > 1 > ratios > PB
-0.14688255015613638
Annuals > 1 > ratios > ROE
1059.065534499722
Annuals > 1 > ratios > ROA
-159.0684727315366
Annuals > 1 > ratios > FCF
-1481966
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-5.811722536824107
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
190577
Annuals > 2 > income Statement > cost Of Revenue
148653
Annuals > 2 > income Statement > gross Profit
190577
Annuals > 2 > income Statement > operating Expenses
642892
Annuals > 2 > income Statement > operating Income
-452315
Annuals > 2 > income Statement > interest Expense
58818
Annuals > 2 > income Statement > pretax Income
-1048878
Annuals > 2 > income Statement > net Income
-1048878
Annuals > 2 > income Statement > eps
-0.06827967796886449
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
15361496
Annuals > 2 > income Statement > income Tax Expense
58818
Annuals > 2 > income Statement > EBITDA
-499799
Annuals > 2 > income Statement > operating Margin
-237.33976293046902
Annuals > 2 > income Statement > total Other Income Expense Net
-596563
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
297627
Annuals > 2 > balance Sheet > short Term Investments
1
Annuals > 2 > balance Sheet > receivables
26441
Annuals > 2 > balance Sheet > inventories
4629
Annuals > 2 > balance Sheet > total Current Assets
858247
Annuals > 2 > balance Sheet > property Plant Equipment
418844
Annuals > 2 > balance Sheet > total Assets
1277092
Annuals > 2 > balance Sheet > payables
432942
Annuals > 2 > balance Sheet > short Term Debt
683736
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1918326
Annuals > 2 > balance Sheet > equity
-641234
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-1048878
Annuals > 2 > cash Flow > depreciation
148653
Annuals > 2 > cash Flow > change In Working Capital
423754
Annuals > 2 > cash Flow > cash From Operations
-23516
Annuals > 2 > cash Flow > capital Expenditures
456139
Annuals > 2 > cash Flow > cash From Investing
-436139
Annuals > 2 > cash Flow > cash From Financing
727600
Annuals > 2 > cash Flow > net Change In Cash
267945
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.06827967796886449
Annuals > 2 > ratios > PB
-0.011978073526980791
Annuals > 2 > ratios > ROE
163.57180062192583
Annuals > 2 > ratios > ROA
-82.13018326009403
Annuals > 2 > ratios > FCF
-479655
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-2.516856703589625
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
194686
Annuals > 3 > income Statement > cost Of Revenue
65560
Annuals > 3 > income Statement > gross Profit
129126
Annuals > 3 > income Statement > operating Expenses
3220860
Annuals > 3 > income Statement > operating Income
-3026174
Annuals > 3 > income Statement > interest Expense
73220
Annuals > 3 > income Statement > pretax Income
-3192836
Annuals > 3 > income Statement > net Income
-3192836
Annuals > 3 > income Statement > eps
-0.3565015807241206
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
8956022
Annuals > 3 > income Statement > income Tax Expense
73220
Annuals > 3 > income Statement > EBITDA
-3054056
Annuals > 3 > income Statement > operating Margin
-1554.3870642984086
Annuals > 3 > income Statement > total Other Income Expense Net
-166662
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
29681
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
2935
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
85571
Annuals > 3 > balance Sheet > property Plant Equipment
793853
Annuals > 3 > balance Sheet > total Assets
879424
Annuals > 3 > balance Sheet > payables
306673
Annuals > 3 > balance Sheet > short Term Debt
573182
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1405218
Annuals > 3 > balance Sheet > equity
-525794
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3192836
Annuals > 3 > cash Flow > depreciation
65560
Annuals > 3 > cash Flow > change In Working Capital
620100
Annuals > 3 > cash Flow > cash From Operations
-113757
Annuals > 3 > cash Flow > capital Expenditures
215060
Annuals > 3 > cash Flow > cash From Investing
-215060
Annuals > 3 > cash Flow > cash From Financing
350000
Annuals > 3 > cash Flow > net Change In Cash
21307
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.3565015807241206
Annuals > 3 > ratios > PB
-0.008516664321007847
Annuals > 3 > ratios > ROE
607.2408585872034
Annuals > 3 > ratios > ROA
-363.05991194236225
Annuals > 3 > ratios > FCF
-328817
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.6889606854113803
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.0009106690204378055
Valuation > metrics > PB
-0.013654113640545229
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
2.4868756587963605
Profitability > metrics > ROA
-42.04704035352948
Profitability > final Score
20
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-12.674074074074074
Risk > final Score
-21
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.07337578530820348
Liquidity > metrics > Quick Ratio
0.07337578530820348
Liquidity > final Score
14
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
70
Prev Profitabilities > 0
36
Prev Profitabilities > 1
48
Prev Profitabilities > 2
60
Prev Risks > 0
-476
Prev Risks > 1
-677
Prev Risks > 2
70
Prev Liquidities > 0
14
Prev Liquidities > 1
16
Prev Liquidities > 2
14
Updated At
2026-01-20T21:24:33.616Z
Earnings History > 0 > period
2023-09-30
Earnings History > 0 > report Date
2023-12-08
Earnings History > 0 > date
2023-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
CAD
Earnings History > 0 > eps Actual
-0.01
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2023-06-30
Earnings History > 1 > report Date
2023-06-30
Earnings History > 1 > date
2023-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
CAD
Earnings History > 1 > eps Actual
-0.0028
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2023-03-31
Earnings History > 2 > report Date
2023-03-31
Earnings History > 2 > date
2023-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
CAD
Earnings History > 2 > eps Actual
-0.0039
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2022-12-31
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
CAD
Earnings History > 3 > eps Actual
0.0019
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-09-30
Earnings History > 4 > report Date
2022-09-30
Earnings History > 4 > date
2022-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-0.006
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-06-30
Earnings History > 5 > report Date
2022-06-30
Earnings History > 5 > date
2022-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.02
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2022-03-31
Earnings History > 6 > report Date
2022-03-31
Earnings History > 6 > date
2022-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.0144
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-12-31
Earnings History > 7 > report Date
2021-12-31
Earnings History > 7 > date
2021-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
0.0148
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2021-09-30
Earnings History > 8 > report Date
2021-09-30
Earnings History > 8 > date
2021-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.0069
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2021-06-30
Earnings History > 9 > report Date
2021-06-30
Earnings History > 9 > date
2021-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.0225
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2021-03-31
Earnings History > 10 > report Date
2021-03-31
Earnings History > 10 > date
2021-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.0206
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-12-31
Earnings History > 11 > report Date
2020-12-31
Earnings History > 11 > date
2020-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.0191
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2020-09-30
Earnings History > 12 > report Date
2020-09-30
Earnings History > 12 > date
2020-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.0067
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2020-06-30
Earnings History > 13 > report Date
2020-06-30
Earnings History > 13 > date
2020-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.0123
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2020-03-31
Earnings History > 14 > report Date
2020-03-31
Earnings History > 14 > date
2020-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
CAD
Earnings History > 14 > eps Actual
-0.0089
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2019-12-31
Earnings History > 15 > report Date
2019-12-31
Earnings History > 15 > date
2019-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
CAD
Earnings History > 15 > eps Actual
-0.1015
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2019-09-30
Earnings History > 16 > report Date
2019-09-30
Earnings History > 16 > date
2019-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
CAD
Earnings History > 16 > eps Actual
-0.0211
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2019-06-30
Earnings History > 17 > report Date
2019-06-30
Earnings History > 17 > date
2019-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
CAD
Earnings History > 17 > eps Actual
-0.1255
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-TORE, a product based on organic plant nutrition for patients with overt clinical need for rational enhanced caloric intake and micronutrient supplementation. It also develops edible oils, moringa, hops, cannabis sativa, pharma, sea cucumber, ginseng, and functional fungi ingredients; and anti-virals and phytomedicinalization. In addition, the company flash-freezes active ingredients, oils, and oleoresins for use as ingredients in food, nutraceuticals, and other consumer products. The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. is based in Coquitlam, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of AREV NanoTec Brands Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2023-09-30
EPS Actual
-0.01
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2023-09-30)
(Last Updated 2023-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.